VEA

Virtus ETF Advisers Portfolio holdings

AUM $75.7M
This Quarter Return
+10.35%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$113M
AUM Growth
+$113M
Cap. Flow
-$8.35M
Cap. Flow %
-7.38%
Top 10 Hldgs %
14.17%
Holding
280
New
34
Increased
62
Reduced
100
Closed
19

Top Buys

1
FNCL icon
Fidelity MSCI Financials Index ETF
FNCL
$1.41M
2
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
$1.15M
3
VSTM icon
Verastem
VSTM
$985K
4
ARWR icon
Arrowhead Research
ARWR
$933K
5
RNAC icon
Cartesian Therapeutics
RNAC
$884K

Top Sells

1
FTEC icon
Fidelity MSCI Information Technology Index ETF
FTEC
$2.82M
2
MDGL icon
Madrigal Pharmaceuticals
MDGL
$1.94M
3
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$1.32M
4
JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
$1.32M
5
SRPT icon
Sarepta Therapeutics
SRPT
$1.19M

Sector Composition

1 Healthcare 77.9%
2 Financials 0.8%
3 Technology 0.58%
4 Consumer Discretionary 0.4%
5 Energy 0.33%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
EXEL icon
26
Exelixis
EXEL
$10.1B
$799K 0.71% 37,132 +2,653 +8% +$57.1K
IMMU
27
DELISTED
Immunomedics Inc
IMMU
$799K 0.71% 33,761 -26,601 -44% -$630K
REGN icon
28
Regeneron Pharmaceuticals
REGN
$61.5B
$798K 0.71% 2,313 -39 -2% -$13.5K
APLS icon
29
Apellis Pharmaceuticals
APLS
$3.48B
$797K 0.7% +36,223 New +$797K
CBIO
30
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
$797K 0.7% 49,395 +2,870 +6% +$46.3K
BHVN
31
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$796K 0.7% +20,154 New +$796K
BOLD
32
DELISTED
Audentes Therapeutics, Inc
BOLD
$795K 0.7% 20,810 -5,308 -20% -$203K
KURA icon
33
Kura Oncology
KURA
$686M
$794K 0.7% 43,633 -11,650 -21% -$212K
IOVA icon
34
Iovance Biotherapeutics
IOVA
$807M
$793K 0.7% 61,951 -28,975 -32% -$371K
PRTA icon
35
Prothena Corp
PRTA
$441M
$793K 0.7% 54,358 +33,902 +166% +$495K
AKCA
36
DELISTED
Akcea Therapeutics, Inc. Common Stock
AKCA
$790K 0.7% 33,315 -6,036 -15% -$143K
LGND icon
37
Ligand Pharmaceuticals
LGND
$3.15B
$787K 0.7% 3,800 -2,971 -44% -$615K
GTHX
38
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$787K 0.7% 18,103 -20,022 -53% -$870K
LOXO
39
DELISTED
Loxo Oncology, Inc
LOXO
$787K 0.7% 4,535 -4,811 -51% -$835K
PBYI icon
40
Puma Biotechnology
PBYI
$254M
$784K 0.69% 13,252 +4,123 +45% +$244K
ONCE
41
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$784K 0.69% 9,477 -10,547 -53% -$873K
SRNE
42
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$783K 0.69% +108,716 New +$783K
GBT
43
DELISTED
Global Blood Therapeutics, Inc.
GBT
$780K 0.69% 17,249 -2,082 -11% -$94.1K
DCPH
44
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$779K 0.69% +19,795 New +$779K
MRNS
45
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$778K 0.69% 109,991 +29,602 +37% +$209K
FAS icon
46
Direxion Daily Financial Bull 3x Shares
FAS
$2.74B
$776K 0.69% 12,324 -11,246 -48% -$708K
TGTX icon
47
TG Therapeutics
TGTX
$4.65B
$776K 0.69% 59,022 -30,898 -34% -$406K
ADAP
48
Adaptimmune Therapeutics
ADAP
$15.6M
$774K 0.68% +65,221 New +$774K
PVLA
49
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
$773K 0.68% 152,550 +26,855 +21% +$136K
FOLD icon
50
Amicus Therapeutics
FOLD
$2.34B
$772K 0.68% 49,455 -9,381 -16% -$146K
1
2
3 4 5